Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.72 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.68 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.68 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | MMP13 | P45452 | 4/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8868735 | 0.92 | RAB9A (0.85) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL5738407 | 0.89 | RAB9A (0.81) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL16756061 | 0.89 | KDM4E (0.80) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL9263164 | 0.89 | KDM4E (0.80) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL1319990 | 0.89 | RAB9A (0.80) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL5680973 | 0.86 | KDM4E (0.76) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL4815909 | 0.85 | KDM4E (0.74) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL31370745 | 0.85 | KDM4E (0.74) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL1104006 | 0.85 | PDGFRB (0.77) | KDM4EALDH1A1HPGDRAB9ANPC1 | |
| SCHEMBL31361409 | 0.85 | PDGFRB (0.77) | KDM4EALDH1A1HPGDRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2948454-B1 | TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETI (IN) | 2017-05-31 | — | — | EP | claimed |
| US-9447105-B2 | Triazine compounds and a process for preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-09-20 | — | — | US | claimed |
| US-20150353566-A1 | TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-10 | — | — | US | claimed |
| EP-2948454-A1 | TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | Council of Scientific & Industrial Research An Indian registered body incorporated under the Registration of Societies Act (Act XXI of 1860) (IN) | 2015-12-02 | — | — | EP | claimed |
| WO-2014115171-A1 | TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-07-31 | — | — | WO | claimed |
| US-20240067639-A1 | SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS | University of Florida Research Foundation, Incorporation (US) | 2024-02-29 | — | — | US | disclosed |
| US-20240067639-A1 | SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS | University of Florida Research Foundation, Incorporation (US) | 2024-02-29 | — | — | US | disclosed |
| US-20240067639-A1 | SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS | University of Florida Research Foundation, Incorporation (US) | 2024-02-29 | — | — | US | disclosed |
| US-20230339915-A1 | MODULATORS OF ALPHA-1 ANTITRYPSIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-10-26 | — | — | US | disclosed |
| US-20230339915-A1 | MODULATORS OF ALPHA-1 ANTITRYPSIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-10-26 | — | — | US | disclosed |
| US-20230339915-A1 | MODULATORS OF ALPHA-1 ANTITRYPSIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-10-26 | — | — | US | disclosed |
| CN-115806570-B | Peptoid derivative, pharmaceutical composition and application thereof | 南京知和医药科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| US-4269924-A | REDUCTION OF INTERIMAGE EFFECTS AND IMPROVED COLOR SEPARATION EFFECTED BY SPECIAL POSITIONING OF THE EMULSION LAYERS TO ACT AS DIFFUSION BARRIERS | AGFA-GEVAERT N.V. (BE) | 1981-05-26 | — | — | US | disclosed |
| US-4256831-A | FOR COLOR DIFFUSION TRANSFER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-03-17 | — | — | US | disclosed |
| EP-0024852-A1 | 2,3-Dihydro-1H-indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing these derivatives and their preparation | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-03-11 | — | — | EP | disclosed |
| US-4247629-A | FOR DIFFUSION TRANSFER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-01-27 | — | — | US | disclosed |
| US-4245028-A | CONTAINING AN AZO DYE RELEASING REDOX COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1981-01-13 | — | — | US | disclosed |
| US-4179291-A | SILVER HALIDE EMULSION WITH A NON-DIFFUSIBLE DYE PRODUCING COMPOUND | AGFA-GEVAERT, A.G. (DE) | 1979-12-18 | — | — | US | disclosed |
| EP-0003376-A1 | Photographic material suited for the production of multicolour images by means of diffusion transfer of complexed silver halide | AGFA-GEVAERT N.V. (BE) | 1979-08-08 | — | — | EP | disclosed |
| US-4118395-A | Method for the production of indolyl lactones | FRANTSITS WERNER J | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067639-A1 | SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS | FUS, SNRPE, RRBP1 | KDM4E 1687/4885ALDH1A1 4793/4885HPGD 4750/4885 |
| US-20150353566-A1 | TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | TPH2, IDO2, INMT | KDM4E 862/4885ALDH1A1 2885/4885HPGD 2149/4885 |
| US-20230339915-A1 | MODULATORS OF ALPHA-1 ANTITRYPSIN | SERPINA2, SERPINA3, SERPINB1 | KDM4E 4795/4885ALDH1A1 578/4885HPGD 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.